Option Care Health Inc (OPCH)
Industry Medical Care Facilities
This stock can be held in an Investment ISA and an Investment Account
Sell
$31.97
Buy
$32.87
$-0.56 (-1.70%)
Prices updated at 18 Dec 2025, 23:25 EST
| Prices minimum 15 mins delay
Prices in USD
BioScrip Inc provides home infusion & other home healthcare services to patients, physicians, hospitals, healthcare payors & pharmaceutical manufacturers to provide clinical management solutions & delivers cost-effective access to medications.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 4,302m | 4,998m | |
| 981m | 1,013m | |
| 315m | 322m | |
| 7.31 | 6.44 | |
| 267m | 212m | |
| 472m | 396m | |
| Sales, General and administrative | 607m | 630m |
| Interest expenses | 51m | 49m |
| Provision for income taxes | 92m | 72m |
| Operating expenses | 667m | 691m |
| Income before taxes | 359m | 284m |
| Net income available to common shareholders | 267m | 212m |
| 1.49 | 1.23 | |
| Net interest income | -51m | -49m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 1.48 | 1.23 |
| Free cash flow per share | 1.7805 | 1.6767 |
| Book value/share | 8.2491 | 8.5783 |
| Debt equity ratio | 0.803374 | 0.84702 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 1,094m | 1,323m |
| Current liabilities | 618m | 780m |
| Total capital | 2,478m | 2,509m |
| Total debt | 1,166m | 1,218m |
| Total equity | 1,422m | 1,404m |
| Total non current liabilities | - | - |
| Loans | 1,057m | 1,105m |
| Total assets | 3,217m | 3,422m |
| Total liabilities | - | - |
| Cash and cash equivalents | 344m | 413m |
| Common stock | 175m | 166m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 294m | 344m |
| Cash dividends paid | - | - |
| 329m | 288m | |
| Investments (gains) losses | -57m | -36m |
| 344m | 413m | |
| Net income | - | - |
| 371m | 323m | |
| -42m | -36m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.